Home Healthcare Pharmaceuticals IV and Oral Iron Drugs Market

IV and Oral Iron Drugs Market Size, Share & Trends Analysis Report By Drug Type (Iron Dextran, Iron Sucrose, Ferric Carboxymaltose, Ferric Gluconate, Others), By Route of Administration (IV, Oral), By Application (Chronic Kidney Diseases, Inflammatory Bowel Diseases, Oncology-induced Anemia, Iron Deficiency Anemia, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 13, 2026 | Author: Mitiksha Koul | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. IV and Oral Iron Drugs Market Size Analysis
    1. Introduction
    2. IV and Oral Iron Drugs Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Iron Dextran
      2. Iron Sucrose
      3. Ferric Carboxymaltose
      4. Ferric Gluconate
      5. Others
    3. IV and Oral Iron Drugs Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. IV
      2. Oral
    4. IV and Oral Iron Drugs Market Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
      1. Chronic Kidney Diseases
      2. Inflammatory Bowel Diseases
      3. Oncology-induced Anemia
      4. Iron Deficiency Anemia
      5. Others
  7. North America IV and Oral Iron Drugs Market Size Analysis
    1. Introduction
    2. IV and Oral Iron Drugs Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Iron Dextran
      2. Iron Sucrose
      3. Ferric Carboxymaltose
      4. Ferric Gluconate
      5. Others
    3. IV and Oral Iron Drugs Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. IV
      2. Oral
    4. IV and Oral Iron Drugs Market Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
      1. Chronic Kidney Diseases
      2. Inflammatory Bowel Diseases
      3. Oncology-induced Anemia
      4. Iron Deficiency Anemia
      5. Others
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Iron Dextran
        2. Iron Sucrose
        3. Ferric Carboxymaltose
        4. Ferric Gluconate
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. IV
        2. Oral
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Chronic Kidney Diseases
        2. Inflammatory Bowel Diseases
        3. Oncology-induced Anemia
        4. Iron Deficiency Anemia
        5. Others
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Iron Dextran
        2. Iron Sucrose
        3. Ferric Carboxymaltose
        4. Ferric Gluconate
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. IV
        2. Oral
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Chronic Kidney Diseases
        2. Inflammatory Bowel Diseases
        3. Oncology-induced Anemia
        4. Iron Deficiency Anemia
        5. Others
  8. Europe IV and Oral Iron Drugs Market Size Analysis
    1. Introduction
    2. IV and Oral Iron Drugs Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Iron Dextran
      2. Iron Sucrose
      3. Ferric Carboxymaltose
      4. Ferric Gluconate
      5. Others
    3. IV and Oral Iron Drugs Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. IV
      2. Oral
    4. IV and Oral Iron Drugs Market Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
      1. Chronic Kidney Diseases
      2. Inflammatory Bowel Diseases
      3. Oncology-induced Anemia
      4. Iron Deficiency Anemia
      5. Others
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Iron Dextran
        2. Iron Sucrose
        3. Ferric Carboxymaltose
        4. Ferric Gluconate
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. IV
        2. Oral
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Chronic Kidney Diseases
        2. Inflammatory Bowel Diseases
        3. Oncology-induced Anemia
        4. Iron Deficiency Anemia
        5. Others
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Iron Dextran
        2. Iron Sucrose
        3. Ferric Carboxymaltose
        4. Ferric Gluconate
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. IV
        2. Oral
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Chronic Kidney Diseases
        2. Inflammatory Bowel Diseases
        3. Oncology-induced Anemia
        4. Iron Deficiency Anemia
        5. Others
    7. France
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Iron Dextran
        2. Iron Sucrose
        3. Ferric Carboxymaltose
        4. Ferric Gluconate
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. IV
        2. Oral
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Chronic Kidney Diseases
        2. Inflammatory Bowel Diseases
        3. Oncology-induced Anemia
        4. Iron Deficiency Anemia
        5. Others
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Iron Dextran
        2. Iron Sucrose
        3. Ferric Carboxymaltose
        4. Ferric Gluconate
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. IV
        2. Oral
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Chronic Kidney Diseases
        2. Inflammatory Bowel Diseases
        3. Oncology-induced Anemia
        4. Iron Deficiency Anemia
        5. Others
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Iron Dextran
        2. Iron Sucrose
        3. Ferric Carboxymaltose
        4. Ferric Gluconate
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. IV
        2. Oral
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Chronic Kidney Diseases
        2. Inflammatory Bowel Diseases
        3. Oncology-induced Anemia
        4. Iron Deficiency Anemia
        5. Others
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Iron Dextran
        2. Iron Sucrose
        3. Ferric Carboxymaltose
        4. Ferric Gluconate
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. IV
        2. Oral
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Chronic Kidney Diseases
        2. Inflammatory Bowel Diseases
        3. Oncology-induced Anemia
        4. Iron Deficiency Anemia
        5. Others
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Iron Dextran
        2. Iron Sucrose
        3. Ferric Carboxymaltose
        4. Ferric Gluconate
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. IV
        2. Oral
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Chronic Kidney Diseases
        2. Inflammatory Bowel Diseases
        3. Oncology-induced Anemia
        4. Iron Deficiency Anemia
        5. Others
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Iron Dextran
        2. Iron Sucrose
        3. Ferric Carboxymaltose
        4. Ferric Gluconate
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. IV
        2. Oral
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Chronic Kidney Diseases
        2. Inflammatory Bowel Diseases
        3. Oncology-induced Anemia
        4. Iron Deficiency Anemia
        5. Others
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Iron Dextran
        2. Iron Sucrose
        3. Ferric Carboxymaltose
        4. Ferric Gluconate
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. IV
        2. Oral
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Chronic Kidney Diseases
        2. Inflammatory Bowel Diseases
        3. Oncology-induced Anemia
        4. Iron Deficiency Anemia
        5. Others
  9. APAC IV and Oral Iron Drugs Market Size Analysis
    1. Introduction
    2. IV and Oral Iron Drugs Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Iron Dextran
      2. Iron Sucrose
      3. Ferric Carboxymaltose
      4. Ferric Gluconate
      5. Others
    3. IV and Oral Iron Drugs Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. IV
      2. Oral
    4. IV and Oral Iron Drugs Market Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
      1. Chronic Kidney Diseases
      2. Inflammatory Bowel Diseases
      3. Oncology-induced Anemia
      4. Iron Deficiency Anemia
      5. Others
    5. China
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Iron Dextran
        2. Iron Sucrose
        3. Ferric Carboxymaltose
        4. Ferric Gluconate
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. IV
        2. Oral
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Chronic Kidney Diseases
        2. Inflammatory Bowel Diseases
        3. Oncology-induced Anemia
        4. Iron Deficiency Anemia
        5. Others
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Iron Dextran
        2. Iron Sucrose
        3. Ferric Carboxymaltose
        4. Ferric Gluconate
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. IV
        2. Oral
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Chronic Kidney Diseases
        2. Inflammatory Bowel Diseases
        3. Oncology-induced Anemia
        4. Iron Deficiency Anemia
        5. Others
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Iron Dextran
        2. Iron Sucrose
        3. Ferric Carboxymaltose
        4. Ferric Gluconate
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. IV
        2. Oral
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Chronic Kidney Diseases
        2. Inflammatory Bowel Diseases
        3. Oncology-induced Anemia
        4. Iron Deficiency Anemia
        5. Others
    8. India
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Iron Dextran
        2. Iron Sucrose
        3. Ferric Carboxymaltose
        4. Ferric Gluconate
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. IV
        2. Oral
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Chronic Kidney Diseases
        2. Inflammatory Bowel Diseases
        3. Oncology-induced Anemia
        4. Iron Deficiency Anemia
        5. Others
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Iron Dextran
        2. Iron Sucrose
        3. Ferric Carboxymaltose
        4. Ferric Gluconate
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. IV
        2. Oral
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Chronic Kidney Diseases
        2. Inflammatory Bowel Diseases
        3. Oncology-induced Anemia
        4. Iron Deficiency Anemia
        5. Others
    10. Singapore
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Iron Dextran
        2. Iron Sucrose
        3. Ferric Carboxymaltose
        4. Ferric Gluconate
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. IV
        2. Oral
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Chronic Kidney Diseases
        2. Inflammatory Bowel Diseases
        3. Oncology-induced Anemia
        4. Iron Deficiency Anemia
        5. Others
    11. Taiwan
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Iron Dextran
        2. Iron Sucrose
        3. Ferric Carboxymaltose
        4. Ferric Gluconate
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. IV
        2. Oral
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Chronic Kidney Diseases
        2. Inflammatory Bowel Diseases
        3. Oncology-induced Anemia
        4. Iron Deficiency Anemia
        5. Others
    12. South East Asia
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Iron Dextran
        2. Iron Sucrose
        3. Ferric Carboxymaltose
        4. Ferric Gluconate
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. IV
        2. Oral
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Chronic Kidney Diseases
        2. Inflammatory Bowel Diseases
        3. Oncology-induced Anemia
        4. Iron Deficiency Anemia
        5. Others
    13. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Iron Dextran
        2. Iron Sucrose
        3. Ferric Carboxymaltose
        4. Ferric Gluconate
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. IV
        2. Oral
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Chronic Kidney Diseases
        2. Inflammatory Bowel Diseases
        3. Oncology-induced Anemia
        4. Iron Deficiency Anemia
        5. Others
  10. Middle East and Africa IV and Oral Iron Drugs Market Size Analysis
    1. Introduction
    2. IV and Oral Iron Drugs Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Iron Dextran
      2. Iron Sucrose
      3. Ferric Carboxymaltose
      4. Ferric Gluconate
      5. Others
    3. IV and Oral Iron Drugs Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. IV
      2. Oral
    4. IV and Oral Iron Drugs Market Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
      1. Chronic Kidney Diseases
      2. Inflammatory Bowel Diseases
      3. Oncology-induced Anemia
      4. Iron Deficiency Anemia
      5. Others
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Iron Dextran
        2. Iron Sucrose
        3. Ferric Carboxymaltose
        4. Ferric Gluconate
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. IV
        2. Oral
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Chronic Kidney Diseases
        2. Inflammatory Bowel Diseases
        3. Oncology-induced Anemia
        4. Iron Deficiency Anemia
        5. Others
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Iron Dextran
        2. Iron Sucrose
        3. Ferric Carboxymaltose
        4. Ferric Gluconate
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. IV
        2. Oral
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Chronic Kidney Diseases
        2. Inflammatory Bowel Diseases
        3. Oncology-induced Anemia
        4. Iron Deficiency Anemia
        5. Others
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Iron Dextran
        2. Iron Sucrose
        3. Ferric Carboxymaltose
        4. Ferric Gluconate
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. IV
        2. Oral
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Chronic Kidney Diseases
        2. Inflammatory Bowel Diseases
        3. Oncology-induced Anemia
        4. Iron Deficiency Anemia
        5. Others
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Iron Dextran
        2. Iron Sucrose
        3. Ferric Carboxymaltose
        4. Ferric Gluconate
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. IV
        2. Oral
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Chronic Kidney Diseases
        2. Inflammatory Bowel Diseases
        3. Oncology-induced Anemia
        4. Iron Deficiency Anemia
        5. Others
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Iron Dextran
        2. Iron Sucrose
        3. Ferric Carboxymaltose
        4. Ferric Gluconate
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. IV
        2. Oral
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Chronic Kidney Diseases
        2. Inflammatory Bowel Diseases
        3. Oncology-induced Anemia
        4. Iron Deficiency Anemia
        5. Others
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Iron Dextran
        2. Iron Sucrose
        3. Ferric Carboxymaltose
        4. Ferric Gluconate
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. IV
        2. Oral
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Chronic Kidney Diseases
        2. Inflammatory Bowel Diseases
        3. Oncology-induced Anemia
        4. Iron Deficiency Anemia
        5. Others
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Iron Dextran
        2. Iron Sucrose
        3. Ferric Carboxymaltose
        4. Ferric Gluconate
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. IV
        2. Oral
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Chronic Kidney Diseases
        2. Inflammatory Bowel Diseases
        3. Oncology-induced Anemia
        4. Iron Deficiency Anemia
        5. Others
  11. LATAM IV and Oral Iron Drugs Market Size Analysis
    1. Introduction
    2. IV and Oral Iron Drugs Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Iron Dextran
      2. Iron Sucrose
      3. Ferric Carboxymaltose
      4. Ferric Gluconate
      5. Others
    3. IV and Oral Iron Drugs Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. IV
      2. Oral
    4. IV and Oral Iron Drugs Market Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
      1. Chronic Kidney Diseases
      2. Inflammatory Bowel Diseases
      3. Oncology-induced Anemia
      4. Iron Deficiency Anemia
      5. Others
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Iron Dextran
        2. Iron Sucrose
        3. Ferric Carboxymaltose
        4. Ferric Gluconate
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. IV
        2. Oral
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Chronic Kidney Diseases
        2. Inflammatory Bowel Diseases
        3. Oncology-induced Anemia
        4. Iron Deficiency Anemia
        5. Others
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Iron Dextran
        2. Iron Sucrose
        3. Ferric Carboxymaltose
        4. Ferric Gluconate
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. IV
        2. Oral
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Chronic Kidney Diseases
        2. Inflammatory Bowel Diseases
        3. Oncology-induced Anemia
        4. Iron Deficiency Anemia
        5. Others
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Iron Dextran
        2. Iron Sucrose
        3. Ferric Carboxymaltose
        4. Ferric Gluconate
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. IV
        2. Oral
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Chronic Kidney Diseases
        2. Inflammatory Bowel Diseases
        3. Oncology-induced Anemia
        4. Iron Deficiency Anemia
        5. Others
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Iron Dextran
        2. Iron Sucrose
        3. Ferric Carboxymaltose
        4. Ferric Gluconate
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. IV
        2. Oral
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Chronic Kidney Diseases
        2. Inflammatory Bowel Diseases
        3. Oncology-induced Anemia
        4. Iron Deficiency Anemia
        5. Others
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Iron Dextran
        2. Iron Sucrose
        3. Ferric Carboxymaltose
        4. Ferric Gluconate
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. IV
        2. Oral
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Chronic Kidney Diseases
        2. Inflammatory Bowel Diseases
        3. Oncology-induced Anemia
        4. Iron Deficiency Anemia
        5. Others
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Iron Dextran
        2. Iron Sucrose
        3. Ferric Carboxymaltose
        4. Ferric Gluconate
        5. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. IV
        2. Oral
      4. Market Size & Forecast By Application  2022-2034 (USD MILLION/ Units)
        1. Chronic Kidney Diseases
        2. Inflammatory Bowel Diseases
        3. Oncology-induced Anemia
        4. Iron Deficiency Anemia
        5. Others
  12. Competitive Landscape
    1. IV and Oral Iron Drugs Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. CSL
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Daiichi Sankyo
    3. Covis Pharma
    4. Akebia Therapeutics
    5. Shield Therapeutics
    6. Sanofi
    7. AbbVie Inc.
    8. Pfizer Inc.
    9. Rockwell Medical
    10. Fresenius Medical Care
    11. Zydus Lifesciences
    12. Sun Pharmaceutical Industries
    13. Reddy’s Laboratories
    14. Cipla
    15. Lupin
    16. Emcure Pharmaceuticals
    17. Aurobindo Pharma
    18. Intas Pharmaceuticals
    19. Glenmark Pharmaceuticals
    20. Teva Pharmaceutical Industries
    21. Viatris
    22. Pharmacosmos A/S
    23. Covis Pharma Group
    24. Nippon Shinyaku Co., Ltd.
    25. Hikma Pharmaceuticals PLC
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.